Provided by Tiger Trade Technology Pte. Ltd.

X4 Pharmaceuticals Inc

4.04
-0.2700-6.26%
Post-market: 4.00-0.0400-0.99%16:37 EDT
Volume:320.14K
Turnover:1.34M
Market Cap:367.32M
PE:-2.16
High:4.35
Open:4.31
Low:4.03
Close:4.31
52wk High:8.40
52wk Low:1.35
Shares:90.92M
Float Shares:64.61M
Volume Ratio:0.67
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8726
EPS(LYR):-5.5878
ROE:-75.99%
ROA:-22.85%
PB:1.97
PE(LYR):-0.72

Loading ...

May 07, 2020

Major Issues Report

Current report, item 2.02
Mar 20, 2020

Major Issues Report

Current report, item 5.02
Mar 17, 2020

Major Issues Report

Current report, items 1.01 and 2.03
Mar 13, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2020

Major Issues Report

Current report, item 2.02
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Major Issues Report

Current report, item 5.02
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Major Issues Report

Current report, items 2.02, 7.01, 8.01, and 9.01
Dec 17, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 09, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 03, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 27, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Nov 26, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 14, 2019

Major Issues Report

Current report, items 1.01 and 2.03
Nov 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01